— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$129M +0.5% ▲
5Y CAGR: -25.4%
Gross Profit
$40M -3.7% ▼
5Y CAGR: -13.0%
Operating Income
-$39M -514.9% ▼
Net Income
-$39M -422.3% ▼
EPS (Diluted)
$-1.13 -552.0% ▼
EBITDA
-$39M -514.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2024FY2025
Revenue$590M$544M$186M$128M$129M
YoY Growth+5.9%-7.8%-65.9%+0.0%+0.5%
Cost of Revenue$515M$463M$135M$86M$89M
Gross Profit$75M$81M$50M$42M$40M
Gross Margin12.7%15.0%27.1%32.6%31.3%
R&D Expenses$11M$10M$8M$9M$8M
SG&A Expenses$72M$65M$46M$40M$44M
Operating Expenses$83M$76M$54M$49M$52M
Operating Income-$42M-$25M-$86M$9M-$39M
Operating Margin-7.1%-4.6%-46.2%7.3%-30.0%
Interest Expense$10M$15M$17M-$3M$3M
Income Before Tax-$51M-$40M-$52M$10M-$39M
Tax Expense-$13M-$8M-$6M-$183K$43K
Net Income-$38M-$33M-$46M$12M-$39M
Net Margin-6.5%-6.0%-24.9%9.4%-30.0%
EPS (Diluted)$-1.31$-1.11$-1.57$0.25$-1.13
EBITDA-$26M-$17M-$46M$9M-$39M
Shares Outstanding29M29M29M37M34M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms